ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,475Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 35

$915K Total Retail Price of All Prescriptions

Rank: 9 out of 35

542 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 542 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

16% of this provider’s 542 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 12,420 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 33.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
FUROSEMIDE 617 519 1 1
OMEPRAZOLE 598 447 2 4
LISINOPRIL 503 420 3 5
LEVOTHYROXINE SODIUM 447 355 4 3
PRAVASTATIN SODIUM 401 310 5 32
POTASSIUM CHLORIDE 369 337 6 10
DONEPEZIL HCL 358 357 7 7
METOPROLOL TARTRATE 354 321 8 11
HYDROCHLOROTHIAZIDE 347 293 9 22
HYDROCODONE-ACETAMINOPHEN 340 244 S3 10 2
SIMVASTATIN 318 259 11 6
METFORMIN HCL 295 242 12 19
CARVEDILOL 264 223 13 25
AMLODIPINE BESYLATE 263 217 14 9
CITALOPRAM HBR 235 185 15 13
TRAMADOL HCL 217 189 16 24
GABAPENTIN 205 163 17 14
PANTOPRAZOLE SODIUM 204 165 18 37
POLYETHYLENE GLYCOL 3350 186 122 19 15
ATENOLOL 186 160 19 31
NAMENDA 170 170 21 12
ADVAIR DISKUS 161 131 22 46
METOPROLOL SUCCINATE 159 144 23 20
ESCITALOPRAM OXALATE 156 135 24 30
KLOR-CON M20 147 119 25 73
ALENDRONATE SODIUM 143 117 26 33
ATORVASTATIN CALCIUM 131 103 27 28
FENOFIBRATE 124 106 28 132
JANUVIA 124 104 28 125
CLOPIDOGREL 121 104 30 34
WARFARIN SODIUM 117 109 31 8
LOSARTAN POTASSIUM 116 112 32 38
MIRTAZAPINE 116 116 32 16
RISPERIDONE 114 101 34 27
NEXIUM 105 69 35 50
ZOLPIDEM TARTRATE 104 61 36 41
LEXAPRO 103 70 37 98
SPIRIVA 102 79 38 61
TAMSULOSIN HCL 98 94 39 29
LEVETIRACETAM 98 26 39 53
PLAVIX 95 87 41 56
PROAIR HFA 88 63 42 114
SERTRALINE HCL 84 59 43 18
FAMOTIDINE 82 72 44 35
ALBUTEROL SULFATE 81 80 45 58
SYMBICORT 81 65 45 266
ROPINIROLE HCL 81 41 45 69
ALLOPURINOL 79 61 48 47
PREDNISONE 75 58 49 36
DILTIAZEM ER 75 73 49 138
LANTUS 73 73 51 26
FLUOXETINE HCL 73 60 51 63
DOXYCYCLINE HYCLATE 71 54 53 66
ISOSORBIDE MONONITRATE ER 69 62 54 43
OXYBUTYNIN CHLORIDE 68 65 55 86
FENTANYL 68 64 S2 55 52
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 66 55 60
EXELON 68 68 55 59
LANTUS SOLOSTAR 66 39 59 108
GEMFIBROZIL 65 44 60 198
SINGULAIR 59 45 61 113
FLUTICASONE PROPIONATE 59 42 61 62
BACLOFEN 58 17 63 92
BUMETANIDE 58 58 63 168
RANITIDINE HCL 58 31 63 45
CEPHALEXIN 55 49 66 50
NOVOLOG 54 38 67 42
GLYBURIDE 54 39 R 67 209
TRAZODONE HCL 54 32 67 23
CLONIDINE HCL 53 37 70 76
SPIRONOLACTONE 50 34 71 54
CRESTOR 50 40 71 71
DIOVAN 50 50 71 66
NASONEX 50 40 71 236
AZITHROMYCIN 50 38 71 57
IPRATROPIUM-ALBUTEROL 50 50 71 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.